IMNN
NASDAQ · Biotechnology
Imunon Inc
$3.27
+0.20 (+6.51%)
Open$3.03
Previous Close$3.07
Day High$3.36
Day Low$3.03
52W High$27.72
52W Low$13.24
Volume—
Avg Volume554.7K
Market Cap11.12M
P/E Ratio16.86
EPS$1.28
SectorBiotechnology
Analyst Ratings
Strong Buy
10 analysts
Price Target
+656.6% upside
Current
$3.27
$3.27
Target
$24.74
$24.74
$16.96
$24.74 avg
$28.19
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 4.58M | 4.80M | 3.77M |
| Net Income | 640.0K | 637.0K | 538.3K |
| Profit Margin | 14.0% | 13.3% | 14.3% |
| EBITDA | 1.20M | 1.08M | 968.7K |
| Free Cash Flow | 434.6K | 468.2K | 383.2K |
| Rev Growth | +11.7% | 0.0% | +15.1% |
| Debt/Equity | 0.17 | 0.18 | 0.18 |
Dividend
Dividend Yield1.71%
Annual Dividend$0.37
Payout Ratio28.9%
Frequencyquarterly
Ex-DividendMar 23, 2026
Pay DateApr 8, 2026
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |